Cargando…
Impact of COVID‐19 on pacemaker implant
OBJECTIVES: The purpose of this article was to determine the change in the volume of pacemaker implantations with the COVID‐2019 pandemic and to assess the change in the number of pacemaker implants according to etiology during the pandemic. BACKGROUND: The establishment of a mandatory social isolat...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404435/ https://www.ncbi.nlm.nih.gov/pubmed/32837668 http://dx.doi.org/10.1002/joa3.12411 |
_version_ | 1783567136818462720 |
---|---|
author | Gonzales‐Luna, Ana C. Torres‐Valencia, Javier O. Alarcón‐Santos, Javier E. Segura‐Saldaña, Pedro A. |
author_facet | Gonzales‐Luna, Ana C. Torres‐Valencia, Javier O. Alarcón‐Santos, Javier E. Segura‐Saldaña, Pedro A. |
author_sort | Gonzales‐Luna, Ana C. |
collection | PubMed |
description | OBJECTIVES: The purpose of this article was to determine the change in the volume of pacemaker implantations with the COVID‐2019 pandemic and to assess the change in the number of pacemaker implants according to etiology during the pandemic. BACKGROUND: The establishment of a mandatory social isolation have generated a decrease in activities in cardiology units. METHODS: Descriptive, cross‐sectional study that used a database of a Peruvian Hospital. Time was divided into three categories: Before COVID period and COVID period including Previous to Social isolation (SI) and Social Isolation. The number of pacemaker implantations were compared per the same amount of time. RESULTS: A reduction in the pacemaker implant of 73% (95% CI: 33‐113; P < .001) was observed during the COVID‐19 pandemic period, and a reduction of 78% of patients with the diagnosis of complete or high‐grade atrioventricular block and a reduction in the de‐novo pacemaker implant was observed, regardless of the etiology. CONCLUSIONS: Our results indicate a very significant reduction (73%) in de‐novo pacemaker implantation during the months of the COVID‐19 pandemic. The reduction in the number of de‐novo pacemaker occurred independent of the etiology. |
format | Online Article Text |
id | pubmed-7404435 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74044352020-08-05 Impact of COVID‐19 on pacemaker implant Gonzales‐Luna, Ana C. Torres‐Valencia, Javier O. Alarcón‐Santos, Javier E. Segura‐Saldaña, Pedro A. J Arrhythm Original Articles OBJECTIVES: The purpose of this article was to determine the change in the volume of pacemaker implantations with the COVID‐2019 pandemic and to assess the change in the number of pacemaker implants according to etiology during the pandemic. BACKGROUND: The establishment of a mandatory social isolation have generated a decrease in activities in cardiology units. METHODS: Descriptive, cross‐sectional study that used a database of a Peruvian Hospital. Time was divided into three categories: Before COVID period and COVID period including Previous to Social isolation (SI) and Social Isolation. The number of pacemaker implantations were compared per the same amount of time. RESULTS: A reduction in the pacemaker implant of 73% (95% CI: 33‐113; P < .001) was observed during the COVID‐19 pandemic period, and a reduction of 78% of patients with the diagnosis of complete or high‐grade atrioventricular block and a reduction in the de‐novo pacemaker implant was observed, regardless of the etiology. CONCLUSIONS: Our results indicate a very significant reduction (73%) in de‐novo pacemaker implantation during the months of the COVID‐19 pandemic. The reduction in the number of de‐novo pacemaker occurred independent of the etiology. John Wiley and Sons Inc. 2020-07-23 /pmc/articles/PMC7404435/ /pubmed/32837668 http://dx.doi.org/10.1002/joa3.12411 Text en © 2020 The Authors. Journal of Arrhythmia published by John Wiley & Sons Australia, Ltd on behalf of Japanese Heart Rhythm Society This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Gonzales‐Luna, Ana C. Torres‐Valencia, Javier O. Alarcón‐Santos, Javier E. Segura‐Saldaña, Pedro A. Impact of COVID‐19 on pacemaker implant |
title | Impact of COVID‐19 on pacemaker implant |
title_full | Impact of COVID‐19 on pacemaker implant |
title_fullStr | Impact of COVID‐19 on pacemaker implant |
title_full_unstemmed | Impact of COVID‐19 on pacemaker implant |
title_short | Impact of COVID‐19 on pacemaker implant |
title_sort | impact of covid‐19 on pacemaker implant |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404435/ https://www.ncbi.nlm.nih.gov/pubmed/32837668 http://dx.doi.org/10.1002/joa3.12411 |
work_keys_str_mv | AT gonzaleslunaanac impactofcovid19onpacemakerimplant AT torresvalenciajaviero impactofcovid19onpacemakerimplant AT alarconsantosjaviere impactofcovid19onpacemakerimplant AT segurasaldanapedroa impactofcovid19onpacemakerimplant |